Nilandron (also known as Anandron)
	Nilandron (also known as Anandron)
	Nilandron (also known as Anandron)
	Nilandron (also known as Anandron)
	Nilandron (also known as Anandron)

Nilandron Drug Information

The drug is an anti-androgen one administered in prostate cancer patients. It acts by blocking the effects of testosterone and in prostate cancer patients it cuts off androgens supply to the cancer mass. The drug is used to prolong the life of prostate cancer patients by treating methastases, in conjunction with surgical castration. To achieve the maximum effect, the treatment should start on the day of surgical castration or on the next day.

Nilandron Drug Dosage

The dosage recommended is 300 mg once daily, in the course of 30 days, and thereafter maintenance therapy of 150 mg once daily. The administration is prescribed on a long term basis. In the event that the disease progresses despite the treatment, the changes in dosage should be made with subsequent consideration of other cancer treatment as may be required. The drug is sold in the dosage of 150 mg. At North Meds the generic drug and brand medication is offered as cheap Nilandron, in dosages of 50 mg and 150 mg. The company offers assorted quantities as discount Nilandron, which can be conveniently ordered online.

Side Effects and Precautions for Nilandron

Side effects of Nilutamide include nausea, dizziness, vomiting, flushing and hepatitis. In some patients who buy Nilandron difficulty in adaptation to low light conditions may be reported following treatment. Such patients should avoid driving at night following administration. Further rare adverse effects include interstitial pneumonitis. Nilandron should be avoided by patients who regularly consume alcohol and by women as it is not indicated for administration in women.

Nilutamide is contraindicated in severe hepatic impairment or severe respiratory impairment patients. In liver disease patients, should any jaundice like symptoms occur, administration should be stopped. Blood clotting should be monitored when administering the drug, as it may interfere with Vitamin K synthesis.

* All trademarks and registered trademarks are the property of their respective owners.